Extendicare Inc. (TSE:EXE – Get Free Report) has earned a consensus recommendation of “Buy” from the eight analysts that are currently covering the stock, Marketbeat reports. Seven analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is C$37.00.
Several equities research analysts have weighed in on the company. Desjardins reduced their price objective on Extendicare from C$40.00 to C$39.00 and set a “buy” rating on the stock in a research note on Monday, August 10th. Canaccord Genuity Group lifted their target price on Extendicare from C$37.00 to C$44.00 and gave the stock a “buy” rating in a report on Monday, August 10th. Royal Bank Of Canada boosted their target price on Extendicare from C$38.00 to C$39.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Finally, National Bank Financial increased their price target on Extendicare from C$34.00 to C$40.00 and gave the company an “outperform” rating in a report on Wednesday, May 27th.
Read Our Latest Stock Report on Extendicare
Extendicare Stock Performance
Extendicare (TSE:EXE – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported C$0.32 earnings per share (EPS) for the quarter. Extendicare had a net margin of 6.13% and a return on equity of 36.33%. The firm had revenue of C$611.04 million for the quarter. On average, analysts expect that Extendicare will post 0.6134729 earnings per share for the current fiscal year.
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which was paid on Monday, August 17th. Shareholders of record on Monday, August 17th were given a dividend of $0.0441 per share. The ex-dividend date was Friday, July 31st. This represents a c) dividend on an annualized basis and a yield of 1.7%. Extendicare’s payout ratio is 39.23%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading
- Five stocks we like better than Extendicare
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
- These 3 Stocks Are Drawing Insider Buyers for Very Different Reasons
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
